Listing is at risk and the usual cures are constrained. Next thing to watch: a reverse-split proxy, a hearings-panel 8-K, or a Form 25.
Radar 95 (high attention) · dilution pressure elevated · listing risk high · governance risk low · runway 6.4 mo · strongest signal: MVLS deficiency (Sep 10, 2026)
What would confirm: Nasdaq 'Pending Suspension' listing, Form 25, hearings-panel denial 8-K, or a reverse-split proxy.
What would prove it wrong: 8-K announcing regained compliance; equity raise that restores stockholders' equity; MVLS back above threshold for 10+ days.
Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.
Independent filings stitched into a thesis, each with what would confirm and what would prove it wrong.
Listing is at risk and the usual cures are constrained. Next thing to watch: a reverse-split proxy, a hearings-panel 8-K, or a Form 25. Exchange deficiency plus a structural reason cure is hard (sub-$5M float, negative equity, no cash, or a reverse split already used). Under Nasdaq's 2026 rules (one reverse split per 12 months; $5M MVLS floor with no cure period from Sept 2026) the usual escape hatches are narrower.
No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.
Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 80 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.
Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.
| Date | Signal | Evidence | Score |
|---|---|---|---|
| Sep 14, 2026 | ▼ Reverse split | “reverse split” language in DEF 14A (DEF 14A) filed 2026-09-14 filing | 29 |
| Sep 10, 2026 | ▼ MVLS deficiency | “mvls deficiency” language in 8-K (8-K) filed 2026-09-10 filing | 63 |
| Sep 10, 2026 | ▼ Hearings panel | “hearings panel” language in 8-K (8-K) filed 2026-09-10 filing | 58 |
| Sep 10, 2026 | ▼ Equity deficiency | “stockholders equity deficiency” language in 8-K (8-K) filed 2026-09-10 filing | 52 |
| Sep 10, 2026 | ▼ Exchange deficiency notice | 8-K Item 3.01 filed 2026-09-10 (accepted 17:00 ET) filing | 48 |
| Sep 10, 2026 | ▼ Delisting language | “delisting notice” language in 8-K (8-K) filed 2026-09-10 filing | 46 |
| Sep 4, 2026 | ▼ Delisting language | “delisting notice” language in 8-K (EX-10.1) filed 2026-09-04 filing | 32 |
| Sep 4, 2026 | ▼ Reverse split | “reverse split” language in PRE 14A (PRE 14A) filed 2026-09-04 filing | 29 |
| Aug 31, 2026 | · Officer/director change | 8-K Item 5.02 filed 2026-08-31 (accepted 17:22 ET) filing | 23 |
| Jun 30, 2026 | ▼ Share count +25% | Shares outstanding 1,437,157 (2026-05-15) -> 2,518,590 (2026-08-14), +75% filing | 38 |
| Jun 30, 2026 | ▼ Near $5M MVLS floor | Public float $2,446,936 (as of 2025-06-30) vs $5M Nasdaq MVLS floor; needs price x shares confirmation filing | 30 |
| Jun 30, 2026 | ▼ Runway 6–12 months | ~6.4 months runway: liquidity $4,414,364 as of 2026-06-30, burn $8,215,483/yr (annualized 180-day YTD operating cash flow [companyfacts]) filing | 24 |
AUID authID Inc. · SOBR SOBR Safe, Inc. · DAIC CID Holdco, Inc. · DFLI Dragonfly Energy Holdings Co · SDST Stardust Power Inc. · ADIL ADIAL PHARMACEUTICALS, INC. · screener →